Jan 23, 2026
The 44th Annual J.P. Morgan Healthcare Conference, held January 12-15, 2026, in San Francisco, revealed a pharmaceutical sector at an inflection point. With major blockbusters facing patent expirations, industry leaders such as Eli Lilly, Novo Nordisk, Bristol Myers Squibb, AbbVie, Bayer, Pfizer, Novartis, Roche, M...
Read More...
Jan 24, 2025
The 43rd Annual J.P. Morgan Healthcare Conference in 2025 showcased the accelerating progress of cell and gene therapies, reaffirming their transformative potential in modern medicine. Despite prior challenges, the field is now demonstrating tangible success, heralding a new era in treating complex and previously u...
Read More...
Jan 24, 2025
The 2025 J.P. Morgan Healthcare Conference ignited a new era of M&A activity, marking the industry’s largest consolidation wave in recent years. The M&A rebound in the healthcare sector has been years in the making, as pharma giants like J&J, GSK, and others face looming patent cliffs, threaten...
Read More...
Jan 17, 2024
From January 8th to 11th, 2024, the 42nd Annual J.P. Morgan Healthcare Conference (JPM24) took center stage in San Francisco, CA, USA. Spanning four dynamic days, this conference saw the active participation of prominent figures from major pharmaceutical, biotechnology, Medtech, HealthTech entities, and emerging fa...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper